<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">xymV3GqyRhqFwYLh7LjQDnC</article-id>
      <article-id pub-id-type="other">00007</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2011000400007</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(11)09600407</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2011005000037</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Preval&#234;ncia e valor progn&#243;stico da dissincronia ventricular na cardiomiopatia chag&#225;sica</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Duarte</surname>
            <given-names>Jussara de Oliveira Pinheiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Magalh&#227;es</surname>
            <given-names>Luiz Pereira de</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santana</surname>
            <given-names>Oto Oliveira</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silva</surname>
            <given-names>Leandro Barros da</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sim&#245;es</surname>
            <given-names>Monique</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Azevedo</surname>
            <given-names>Darluce Oliveira de</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barbosa J&#250;nior</surname>
            <given-names>Oct&#225;vio Alencar</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fagundes</surname>
            <given-names>Alexsandro Alves</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reis</surname>
            <given-names>Francisco Jos&#233; Farias Borges dos</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Correia</surname>
            <given-names>Luis Cl&#225;udio Lemos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Salvador</named-content>
          <named-content content-type="state">Bahia</named-content>
        </addr-line>
        <institution content-type="orgname">Escola Bahiana de Medicina e Sa&#250;de P&#250;blica</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Salvador</named-content>
          <named-content content-type="state">Bahia</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal da Bahia</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>04</month>
        <year>2011</year>
      </pub-date>
      <volume>96</volume>
      <issue>4</issue>
      <fpage>300</fpage>
      <lpage>306</lpage>
      <history>
        <date date-type="received">
          <day>01</day>
          <month>05</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>09</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>02</day>
          <month>09</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A cardiomiopatia chag&#225;sica &#233; uma causa importante de insufici&#234;ncia card&#237;aca na Am&#233;rica Latina. A dissincronia ventricular pode ser um fator de descompensa&#231;&#227;o no curso da doen&#231;a, mas n&#227;o h&#225; dados sobre sua preval&#234;ncia e principais implica&#231;&#245;es progn&#243;sticas, ainda. OBJETIVO: Descrever a preval&#234;ncia e valores progn&#243;sticos da dissincronia ventricular na cardiomiopatia chag&#225;sica. M&#201;TODOS: 56 pacientes com cardiomiopatia chag&#225;sica foram selecionados consecutivamente atrav&#233;s de dois testes sorol&#243;gicos positivos e uma fra&#231;&#227;o de eje&#231;&#227;o (FE) &lt; 45% no ecocardiograma. O ecocardiograma avaliou a presen&#231;a de dissincronia intraventricular utilizando tr&#234;s crit&#233;rios e dissincronia interventricular utilizando 1 crit&#233;rio. Os pacientes foram seguidos por 21 &#177; 14 meses e os eventos card&#237;acos foram definidos como a combina&#231;&#227;o de morte e hospitaliza&#231;&#227;o. RESULTADOS: A m&#233;dia da idade da popula&#231;&#227;o era de 56 &#177; 10 anos, sendo 50% do sexo masculino. A FE m&#233;dia era de 30 &#177; 8% e 87% dos pacientes apresentavam classe funcional I/II (NYHA). A preval&#234;ncia de dissincronia interventricular era de 34% (IC95%: 22%-48%) e a dissincronia intraventricular tinha uma preval&#234;ncia de 85% (IC95%: 75%-93%). A preval&#234;ncia de dissincronia intraventricular era similar em pacientes com dura&#231;&#227;o do QRS &lt; 0,12 s ou &gt; 0,12 s (85% e 89%, respectivamente, p = 0,66). Vinte eventos foram registrados. A incid&#234;ncia de eventos combinados foi similar em pacientes com ou sem dissincronia intraventricular (35% versus 38%, p = 0,9) e aqueles com ou sem dissincronia interventricular (39% versus 34%, p = 0,73). CONCLUS&#195;O: Pacientes com cardiomiopatia chag&#225;sica apresentam alta preval&#234;ncia de dissincronia intraventricular e moderada preval&#234;ncia de dissincronia interventricular. A alta preval&#234;ncia independe da largura do QRS. A dissincronia ventricular n&#227;o tem qualquer valor progn&#243;stico em pacientes com cardiomiopatia chag&#225;sica.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Cardiomiopatia chag&#225;sica</kwd>
        <kwd>disfun&#231;&#227;o ventricular</kwd>
        <kwd>preval&#234;ncia</kwd>
        <kwd>progn&#243;stico</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>01</day>
        <month>04</month>
        <year>2011</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>Preval&#234;ncia e valor progn&#243;stico da dissincronia ventricular na cardiomiopatia chag&#225;sica</bold>
    </p>
    <p>
      <bold>Jussara de Oliveira Pinheiro Duarte<sup>I, II</sup>; Luiz Pereira de Magalh&#227;es<sup>II</sup>; Oto Oliveira Santana<sup>II</sup>; Leandro Barros da Silva<sup>I</sup>; Monique Sim&#245;es<sup>II</sup>; Darluce Oliveira de Azevedo<sup>II</sup>; Oct&#225;vio Alencar Barbosa J&#250;nior<sup>II</sup>; Alexsandro Alves Fagundes<sup>II</sup>; Francisco Jos&#233; Farias Borges dos Reis<sup>II</sup>; Luis Cl&#225;udio Lemos Correia<sup>I</sup></bold>
    </p>
    <p><sup>I</sup>Escola Bahiana de Medicina e Sa&#250;de P&#250;blica, Salvador, BA - Brasil </p>
    <p><sup> II</sup>Hospital Universit&#225;rio Professor Edgar Santos - UFBA, Salvador, BA - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO: </bold> A cardiomiopatia chag&#225;sica &#233; uma causa importante de insufici&#234;ncia card&#237;aca na Am&#233;rica Latina. A dissincronia ventricular pode ser um fator de descompensa&#231;&#227;o no curso da doen&#231;a, mas n&#227;o h&#225; dados sobre sua preval&#234;ncia e principais implica&#231;&#245;es progn&#243;sticas, ainda. </p>
    <p><bold>OBJETIVO:</bold> Descrever a preval&#234;ncia e valores progn&#243;sticos da dissincronia ventricular na cardiomiopatia chag&#225;sica. </p>
    <p><bold>M&#201;TODOS:</bold> 56 pacientes com cardiomiopatia chag&#225;sica foram selecionados consecutivamente atrav&#233;s de dois testes sorol&#243;gicos positivos e uma fra&#231;&#227;o de eje&#231;&#227;o (FE) &lt; 45% no ecocardiograma. O ecocardiograma avaliou a presen&#231;a de dissincronia intraventricular utilizando tr&#234;s crit&#233;rios e dissincronia interventricular utilizando 1 crit&#233;rio. Os pacientes foram seguidos por 21 &#177; 14 meses e os eventos card&#237;acos foram definidos como a combina&#231;&#227;o de morte e hospitaliza&#231;&#227;o. </p>
    <p><bold>RESULTADOS:</bold> A m&#233;dia da idade da popula&#231;&#227;o era de 56 &#177; 10 anos, sendo 50% do sexo masculino. A FE m&#233;dia era de 30 &#177; 8% e 87% dos pacientes apresentavam classe funcional I/II (NYHA). A preval&#234;ncia de dissincronia interventricular era de 34% (IC95%: 22%-48%) e a dissincronia intraventricular tinha uma preval&#234;ncia de 85% (IC95%: 75%-93%). A preval&#234;ncia de dissincronia intraventricular era similar em pacientes com dura&#231;&#227;o do QRS &lt; 0,12 s ou &gt; 0,12 s (85% e 89%, respectivamente, p = 0,66). Vinte eventos foram registrados. A incid&#234;ncia de eventos combinados foi similar em pacientes com ou sem dissincronia intraventricular (35% <italic>versus</italic> 38%, p = 0,9) e aqueles com ou sem dissincronia interventricular (39% <italic>versus</italic> 34%, p = 0,73). </p>
    <p><bold>CONCLUS&#195;O:</bold> Pacientes com cardiomiopatia chag&#225;sica apresentam alta preval&#234;ncia de dissincronia intraventricular e moderada preval&#234;ncia de dissincronia interventricular. A alta preval&#234;ncia independe da largura do QRS. A dissincronia ventricular n&#227;o tem qualquer valor progn&#243;stico em pacientes com cardiomiopatia chag&#225;sica.</p>
    <p><bold>Palavras-chave: </bold> Cardiomiopatia chag&#225;sica, disfun&#231;&#227;o ventricular, preval&#234;ncia, progn&#243;stico.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>Atualmente, &#233; estimado que 10 a 18 milh&#245;es de pessoas estejam infectadas com a Doen&#231;a de Chagas (DC) na Am&#233;rica Latina<sup>1</sup>. A mortalidade devido &#224; cardiomiopatia chag&#225;sica est&#225; intimamente ligada ao grau de envolvimento mioc&#225;rdico<sup>2</sup>. Al&#233;m disso, o risco de morte n&#227;o &#233; o mesmo para todos os pacientes e muitos autores tem tentando identificar caracter&#237;sticas cl&#237;nicas que apontem os pacientes com maior risco. Recentemente, Rassi e cols.<sup>3</sup> publicou um escore de risco com boa acur&#225;cia progn&#243;stica, levando em considera&#231;&#227;o o sexo, a baixa voltagem no eletrocardiograma, cardiomegalia no raio X de t&#243;rax, taquicardia ventricular n&#227;o-sustentada, classe funcional e fra&#231;&#227;o de eje&#231;&#227;o reduzida no ecocardiograma. Al&#233;m da quantifica&#231;&#227;o do grau de disfun&#231;&#227;o ventricular, o ecocardiograma recentemente emergiu como uma ferramenta para determinar a presen&#231;a de dissincronia ventricular, a qual est&#225; relacionada &#224; um pior progn&#243;stico em cardiomiopatias devido &#224; outras etiologias<sup>4-6</sup>. O valor progn&#243;stico da dissincronia ventricular em pacientes com cardiomiopatia chag&#225;sica n&#227;o &#233; conhecido. Recentemente, um estudo controverso chamado "PROSPECT" descreveu o valor e a alta variabilidade inter-observador do ecocardiograma durante a an&#225;lise da dissincronia, e isso &#233; um t&#243;pico a ser analisado nesse estudo com pacientes chag&#225;sicos<sup>7</sup>. Dada a necessidade de novos marcadores de risco nessa doen&#231;a que possam adicionar valor progn&#243;stico ao escore de Rassi e a falta de dados sobre a preval&#234;ncia de dissincronia ventricular nessa popula&#231;&#227;o, avaliamos a dissincronia por ecocardiograma em 56 indiv&#237;duos com cardiomiopatia chag&#225;sica, que foram acompanhados por 21 &#177; 14 meses.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>
      <bold>Popula&#231;&#227;o do estudo</bold>
    </p>
    <p>O estudo foi conduzido na Cl&#237;nica de Cardiomiopatia da Universidade Federal da Bahia. A cardiomiopatia chag&#225;sica foi definida como dois testes sorol&#243;gicos positivos para Doen&#231;a de Chagas (imunofluoresc&#234;ncia e hemaglutina&#231;&#227;o) e fra&#231;&#227;o de eje&#231;&#227;o (FE) &lt; 45% no ecocardiograma. Novos pacientes com essas caracter&#237;sticas foram consecutivamente selecionados de junho de 2005 a agosto de 2008. O estudo foi aprovado pelo Comit&#234; de &#201;tica local. Todos os pacientes assinaram o Termo de Consentimento Livre e Informado. Pacientes com condi&#231;&#245;es card&#237;acas associadas (cardiopatia hipertensiva, valvar ou isqu&#234;mica) foram exclu&#237;dos. Pacientes com fibrila&#231;&#227;o atrial ou extra-s&#237;stoles frequentes foram exclu&#237;dos por que essas arritmias podem prejudicar a avalia&#231;&#227;o da dissincronia atrav&#233;s do ecocardiograma.</p>
    <p>
      <bold>Protocolo do estudo</bold>
    </p>
    <p>Um sistema de ultrassom dispon&#237;vel comercialmente (Vingmed system FiVi/Seven, General Electric-Vingmed, Milwaukee, WI, EUA<italic>)</italic> foi utilizado. Imagens foram obtidas com um transdutor de 3,5 MHz, a uma profundidade de 16 cm nos cortes paraesternal e apical. Os par&#226;metros do Doppler tecidual foram medidos a partir de imagens coloridas de tr&#234;s batimentos card&#237;acos consecutivos atrav&#233;s de an&#225;lise <italic>off-line</italic>. O observador n&#227;o estava ciente da condi&#231;&#227;o cl&#237;nica dos pacientes. A dissincronia intraventricular foi definida pelos seguintes crit&#233;rios: 1) desvio-padr&#227;o (DP) do atraso entre o in&#237;cio da onda R no eletrocardiograma e o pico da velocidade da onda S medida nos 12 segmentos do ventr&#237;culo esquerdo &gt; 33 ms<sup>8-10</sup>; 2) intervalo m&#225;ximo (IM) medido entre quaisquer 2 segmentos &gt; 100 ms<sup>11</sup>; 3) atraso entre os segmentos septo-basal e basal-lateral (SLD) &gt; 60 ms<sup>12</sup>. Para dissincronia interventricular, o Doppler pulsado foi usado. Foi determinada como a diferen&#231;a nos intervalos de tempo da onda Q at&#233; o in&#237;cio do fluxo na art&#233;ria pulmonar, comparada com o intervalo de tempo da onda Q at&#233; o in&#237;cio do fluxo a&#243;rtico, respectivamente. Um valor &gt; 40 ms &#233; considerado anormal<sup>13</sup>. A FE foi calculada atrav&#233;s do m&#233;todo de Simpson modificado. Al&#233;m disso, um registro de Holter de 24 horas foi realizado em todos os pacientes. O escore de Rassi foi calculado como previamente validado<sup>3</sup>. Resumidamente, esse escore leva em considera&#231;&#227;o o sexo, baixa voltagem no eletrocardiograma, cardiomegalia no raio-X de t&#243;rax, taquicardia ventricular n&#227;o-sustentada, classe funcional III/IV e FE reduzida no ecocardiograma.</p>
    <p>Os pacientes foram monitorados de forma regular, a cada 3 meses, atrav&#233;s de consultas ambulatoriais e liga&#231;&#245;es telef&#244;nicas. Eventos cl&#237;nicos tais como morte total, morte cardiovascular e hospitaliza&#231;&#227;o devido &#224; insufici&#234;ncia card&#237;aca ou arritmias foram registrados.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>A frequ&#234;ncia relativa de dissincronia interventricular e intraventricular foi descrita com intervalo de confian&#231;a de 95%. A fim de identificar os preditores na an&#225;lise univariada, dados cl&#237;nicos, eletrocardiogr&#225;ficos e ecocardiogr&#225;ficos, incluindo crit&#233;rios de dissincronia, foram comparados entre pacientes com e sem eventos. As vari&#225;veis categ&#243;ricas foram comparadas atrav&#233;s do Teste Qui-quadrado de Pearson e as vari&#225;veis num&#233;ricas pelo teste <italic>t</italic> de <italic>Student</italic> ou teste de Mann-Whitney; as vari&#225;veis associadas com eventos (p <italic><underline>&lt;</underline></italic> 0,10) foram inclu&#237;das na an&#225;lise de regress&#227;o log&#237;stica para avaliar os preditores independentes. O escore de Rassi foi escolhido ao inv&#233;s de preditores independentes. Com base em um estudo piloto de 28 indiv&#237;duos, onde havia uma preval&#234;ncia de 70% de dissincronia, 56 indiv&#237;duos foram considerados suficientes, dado um erro de precis&#227;o de &#177; 12% e intervalo de confian&#231;a de 95%. Em rela&#231;&#227;o ao valor progn&#243;stico, com base no estudo de Rassi e cols., para definir os fatores progn&#243;sticos independentes na DC e em caso de eventos combinados, foi estimado um risco absoluto de 40%. Assim, 56 pacientes tamb&#233;m foram considerados suficientes, dos quais 39 apresentavam dissincronia e 17 n&#227;o apresentavam dissincronia. Para o grupo com dissincronia, esse risco chega a 60% e para o grupo sem dissincronia, esse risco seria de 20%. Um poder de 80% e um alfa igual a 5% foram dados ao estudo. Na an&#225;lise de variabilidade intra-observador e inter-observador, o coeficiente de variabilidade (CV) foi calculado entre as medidas em rela&#231;&#227;o aos crit&#233;rios de dissincronia intraventricular e interventricular. Para essa an&#225;lise, cerca de 10% da amostra foi utilizada, um total de 6 pacientes, com dois observadores avaliando os &#250;ltimos seis pacientes do estudo. Um valor de p &lt; 0,05 foi considerado significante. O <italic>software</italic> SPSS 14.0 para Windows (<italic>SPSS Inc, Chicago, II)</italic> foi utilizado na an&#225;lise estat&#237;stica.</p>
    <p>N&#227;o havia rela&#231;&#245;es financeiras ou pessoais entre os autores e outros indiv&#237;duos ou organiza&#231;&#245;es que pudessem influenciar suas a&#231;&#245;es de forma inadequada.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>
      <bold>Caracter&#237;sticas basais</bold>
    </p>
    <p>Um grupo de 56 pacientes com cardiomiopatia chag&#225;sica foi estudado, com m&#233;dia de idade de 56 &#177; 10 anos (36 a 79 anos), sendo 50% do sexo masculino, 82% de ascend&#234;ncia africana. Eles haviam sido tratados de forma efetiva em rela&#231;&#227;o &#224; press&#227;o arterial, frequ&#234;ncia card&#237;aca, fun&#231;&#227;o renal e eletr&#243;litos. Em geral, os pacientes estavam sendo submetidos &#224; tratamento m&#233;dico com inibidores de enzima conversora de angiotensina, beta-bloqueadores e bloqueadores de aldosterona, com 93% de uso regular de medicamentos e 87% apresentando classe funcional I/II. Essa boa classe funcional pode ser explicada pela cl&#237;nica espec&#237;fica (Cl&#237;nica de Cardiomiopatia), com diferentes profissionais da sa&#250;de e o uso regular dos medicamentos. Um n&#250;mero significante de pacientes era portador de marca-passo (25%), 23% apresentava bloqueio de ramo direito e 14% apresentava bloqueio de ramo esquerdo. O grau de disfun&#231;&#227;o ventricular esquerda era grave, medido pela fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo de 30 &#177; 8%. As cavidades apresentavam-se dilatadas, com uma m&#233;dia de di&#226;metro diast&#243;lico ventricular esquerdo de 66 &#177; 8 mm. Dist&#250;rbios segmentares de contratilidade ventricular eram muito comuns nessa popula&#231;&#227;o (73%) e o segmento mais comumente afetado era o segmento posterior (56%). Essas caracter&#237;sticas s&#227;o mostradas na <xref ref-type="table" rid="t1">Tabela 1</xref>.</p>
    <table-wrap id="t1">
      <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt01.jpg"/></table-wrap>
    <p>
      <bold>Preval&#234;ncia de dissincronia</bold>
    </p>
    <p>Quando quaisquer dos tr&#234;s crit&#233;rios eram considerados, uma preval&#234;ncia significante de 85% (IC95%: 75% - 93%) de dissincronia intraventricular era observada. Com base no desvio padr&#227;o de 12 segmentos isoladamente, havia uma preval&#234;ncia de 75% (IC95%: 62% - 86%), o crit&#233;rio de intervalo m&#225;ximo estava presente em 79% (IC95%: 65% - 88%) e o atraso septo-lateral, em menor propor&#231;&#227;o, 48% (IC95%: 35% - 62%). A preval&#234;ncia de dissincronia interventricular era 34% (IC95%: 22% -48%) <bold>-</bold> <xref ref-type="table" rid="t2">Tabela 2</xref>. A dissincronia intraventricular permaneceu alta independente da largura do QRS. Estava presente em 89% (IC95%: 74% - 97%) dos pacientes com QRS &gt; 0,12 s e em 84% (IC95%: 62% - 96%) dos pacientes com QRS &lt; 0,12 s (p = 0,66) - <xref ref-type="table" rid="aop02411t03">Tabela 3</xref>. Quando os tr&#234;s crit&#233;rios eram analisados separadamente, nenhuma diferen&#231;a significante foi observada em rela&#231;&#227;o &#224; porcentagem, considerando a largura do QRS nos dois grupos - desvio-padr&#227;o - 81% <italic>vs</italic> 70% (p = 0,31), intervalo m&#225;ximo - 81% <italic>vs</italic> 75% (p = 0,85) e atraso septo-lateral - 47% <italic>vs</italic> 50% (p = 0,78). A dissincronia interventricular era similar entre os subgrupos de QRS &lt; ou &gt; 0,12 s (15% <italic>vs</italic> 44%, p = 0,30). A <xref ref-type="table" rid="aop02411t03">Tabela 3</xref> mostra a m&#233;dia dos 4 crit&#233;rios e valores de p. Quando a porcentagem foi comparada, n&#227;o houve diferen&#231;a. Mas quando as m&#233;dias foram comparadas, o valor foi significante no crit&#233;rio do desvio-padr&#227;o (p = 0,03) e quase significante no crit&#233;rio da diferen&#231;a VE-VD (p = 0,052).</p>
    <p content-type="asset">
      <table-wrap id="aop02411t03">
        <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt02.jpg"/></table-wrap>
    </p>
    <table-wrap id="t2">
      <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt03.jpg"/></table-wrap>
    <p>No momento da avalia&#231;&#227;o da dissincronia, todos os pacientes com marca-passo apresentavam estimula&#231;&#227;o ventricular, com o eletrodo ventricular no &#225;pice do VD. Em rela&#231;&#227;o &#224; pacientes portadores de marca-passo, a dissincronia intraventricular n&#227;o apresentou diferen&#231;a quando as porcentagens e as m&#233;dias foram comparadas (p = 0,09). Entretanto, em rela&#231;&#227;o &#224; dissincronia interventricular, houve diferen&#231;a quando as porcentagens (57% <italic>vs</italic> 24%, p = 0,04), e as m&#233;dias (26 &#177; 22 ms <italic>vs</italic> 48 &#177; 33 ms, p = 0,007) foram comparadas. Quando os pacientes sem marca-passo (n = 42) foram analisados, a preval&#234;ncia de dissincronia intraventricular foi de 90% e a de dissincronia interventricular foi 24%, o que pode explicar esses resultados.</p>
    <p>Outra observa&#231;&#227;o &#233; que os dist&#250;rbios segmentares de contratilidade ventricular foram significantemente mais prevalentes em pacientes com dissincronia intraventricular quando comparados com o grupo sem dissincronia (81% <italic>versus</italic> 57%, p = 0,01). Os dist&#250;rbios segmentares de contratilidade ventricular foram um preditor de dissincronia intraventricular (an&#225;lise multivariada, p=0,01).</p>
    <p>
      <bold>Valor progn&#243;stico da dissincronia</bold>
    </p>
    <p>Durante um per&#237;odo de seguimento de 21 &#177; 14 meses, 20 eventos foram registrados (11 mortes e 9 hospitaliza&#231;&#245;es). A incid&#234;ncia de eventos combinados entre pacientes com e sem dissincronia intraventricular era similar (35% <italic>vs</italic> 38%, p = 0,9). Quando somente mortes foram consideradas, a incid&#234;ncia foi de 19% e 25%, respectivamente (p = 0,68). Na an&#225;lise de presen&#231;a ou aus&#234;ncia de dissincronia interventricular, a incid&#234;ncia de eventos foi de 39% e 34%, respectivamente (p = 0,73). Quando somente mortes foram consideradas, a incid&#234;ncia era de 28% comparada com 16% em pacientes sem dissincronia (p = 0,29).</p>
    <p>Na an&#225;lise univariada, as seguintes vari&#225;veis eram prevalentes em indiv&#237;duos com eventos quando comparados &#224;queles livres de eventos: classe funcional III / IV (30% <italic>vs</italic> 6%, p = 0,02), &#237;ndice cardiotor&#225;cico &gt; 50% (70% <italic>vs</italic> 36%, p = 0,02). A m&#233;dia do escore de Rassi era mais alta em pacientes com eventos (8) quando comparada com os pacientes remanescentes (6, p = 0,01) e a FE era mais baixa em pacientes com eventos (27% &#177; 7% <italic>vs</italic> 32% &#177; 8%, p = 0,02). Quando examinamos os quatro crit&#233;rios para dissincronia, o atraso septo-lateral e a diferen&#231;a VD-VE mostraram um valor de p = 0,10 (<xref ref-type="table" rid="t4">Tabela 4</xref>).</p>
    <table-wrap id="t4">
      <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt04.jpg"/></table-wrap>
    <p>A an&#225;lise multivariada por regress&#227;o log&#237;stica mostrou que o escore de Rassi foi o &#250;nico preditor de eventos combinados (<italic>odds ratio - OR</italic>-1.19; IC95%: 1,02 a 1,40, p=0,01). As vari&#225;veis de dissincronia - atraso septo-lateral (intraventricular) e diferen&#231;a VD-VE (interventricular) n&#227;o foram significantes- atraso septo-lateral - OR = 0,98 (IC95%: 0,97-1.00) e diferen&#231;a VE-VD -1,01 (IC95%: 0,98-1,04) - <xref ref-type="table" rid="t5">Tabela 5</xref>.</p>
    <table-wrap id="t5">
      <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt05.jpg"/></table-wrap>
    <p>
      <bold>Variabilidade inter-observador e intra-observador</bold>
    </p>
    <p>Para as vari&#225;veis desvio-padr&#227;o e intervalo m&#225;ximo, havia uma baixa variabilidade intra-observador (9 e 10%, respectivamente) e uma moderada variabilidade inter-observador (23 e 18%, respectivamente). Em rela&#231;&#227;o ao atraso septo-lateral e a diferen&#231;a VE-VD, ambas as variabilidades intra-observador e inter-observador eram moderadas a altas (23 a 64%). A variabilidade intra-observador (9 a 27%) era muito mais baixa quando comparada &#224; variabilidade inter-observador (18 a 64%) em qualquer uma das quatro vari&#225;veis.</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Esse &#233; o primeiro estudo a avaliar a preval&#234;ncia de dissincronia ventricular e suas implica&#231;&#245;es cl&#237;nicas em indiv&#237;duos com cardiomiopatia chag&#225;sica. Primeiramente, observamos que a dissincronia &#233; uma condi&#231;&#227;o altamente prevalente; segundo, a presen&#231;a de dissincronia pode n&#227;o afetar o progn&#243;stico de indiv&#237;duos com cardiomiopatia chag&#225;sica.</p>
    <p>A preval&#234;ncia de 85% de dissincronia intraventricular deve ser considerada significantemente alta, especialmente quando comparada com outras etiologias, tais como cardiomiopatia isqu&#234;mica e dilatada, com uma preval&#234;ncia relatada de 58% em pacientes com bloqueio do ramo esquerdo e 42% em pacientes com bloqueio do ramo direito associado com bloqueio divisional<sup>14</sup>. Poss&#237;veis explica&#231;&#245;es para essa preval&#234;ncia mais alta em pacientes chag&#225;sicos seriam as altera&#231;&#245;es segmentares secund&#225;rias &#224; &#225;reas de fibrose associadas com o processo inflamat&#243;rio cr&#244;nico e difuso, que &#233; persistente e inerente &#224; essa doen&#231;a<sup>15,16</sup>. Em rela&#231;&#227;o &#224; dissincronia interventricular, nossos achados foram similares &#224;queles relatados em outras etiologias<sup>17</sup>. Nessa popula&#231;&#227;o, nenhuma diferen&#231;a significante foi observada em rela&#231;&#227;o &#224; preval&#234;ncia baseada na largura do QRS, apenas em alguns valores de m&#233;dias de crit&#233;rios de dissincronia intraventricular. Em rela&#231;&#227;o ao crit&#233;rio interventricular, essa diferen&#231;a era mais evidente, mas sem atingir signific&#226;ncia estat&#237;stica, apenas em pacientes com marca-passo. Na literatura, a preval&#234;ncia de dissincronia intraventricular e interventricular tem rela&#231;&#227;o com a largura do QRS em outras etiologias<sup>17</sup>.</p>
    <p>O grau de fibrose em pacientes com Doen&#231;a de Chagas (DC) contradiz os benef&#237;cios da ressincroniza&#231;&#227;o, como o relatado para cardiomiopatias isqu&#234;micas com &#225;reas de cicatrizes transmurais<sup>18,19</sup>. O crit&#233;rio septo-lateral nessa popula&#231;&#227;o era menos prevalente, mas n&#227;o havia rela&#231;&#227;o com a &#225;rea de fibrose. Essa medida &#233; feita na &#225;rea anterior, uma &#225;rea que n&#227;o &#233; normalmente afetada pela DC. Por outro lado, todos os outros crit&#233;rios foram altamente prevalentes e poderiam ser um fator em favor da terapia, j&#225; bem estabelecida em grandes estudos cl&#237;nicos em outras etiologias (CARE-HF e COMPANION)<sup>20-23</sup> e em pequenos estudos na popula&#231;&#227;o chag&#225;sica. Silva e cols.<sup>24</sup> descreveram uma popula&#231;&#227;o de 29 pacientes, metade dos quais chag&#225;sicos, que receberam terapia de ressincroniza&#231;&#227;o e evolu&#237;ram com melhora cl&#237;nica e da fra&#231;&#227;o de eje&#231;&#227;o (FE). Esses indiv&#237;duos podem se beneficiar com a terapia, mas isso n&#227;o pode ser declarado nesse momento e um novo estudo cl&#237;nico &#233; necess&#225;rio para definir essa quest&#227;o.</p>
    <p>Dados anteriores relataram uma rela&#231;&#227;o entre a dissincronia e um pior progn&#243;stico em outras cardiomiopatias. Cho e cols.<sup>6</sup> avaliaram a dissincronia em 106 pacientes com insufici&#234;ncia card&#237;aca e verificaram que a dissincronia era um forte preditor de eventos cl&#237;nicos graves. De forma similar, Bader e cols.<sup>4</sup>, ao descreverem um grupo de 104 pacientes, mostraram que a presen&#231;a de dissincronia intraventricular &#233; um fator determinante de eventos card&#237;acos adversos, independentemente da FE e do QRS. Em oposi&#231;&#227;o, no presente estudo, a dissincronia n&#227;o mostrou ser um marcador em pacientes com cardiomiopatia chag&#225;sica. Poss&#237;veis explica&#231;&#245;es podem ser a alta preval&#234;ncia, com quase todos apresentando dissincronia, e provavelmente a esperada variabilidade do m&#233;todo usado para avaliar a dissincronia. Ao analisar a exatid&#227;o das medidas de dissincronia, podemos observar uma variabilidade intra-observador mais baixa quando comparada &#224; variabilidade inter-observador. Essas medidas refletem, de certa forma, a alta variabilidade desses valores, j&#225; bem estabelecidos na literatura<sup>7-25</sup>. A recente publica&#231;&#227;o do estudo PROSPECT mostrou um baixo valor preditivo do ecocardiograma em rela&#231;&#227;o &#224; dissincronia. Esse estudo corrente mostrou um resultado bastante similar em rela&#231;&#227;o &#224; variabilidade, considerando a mesma vari&#225;vel. Al&#233;m disso, pode explicar o resultado negativo em rela&#231;&#227;o ao progn&#243;stico. Uma sugest&#227;o &#233; que os crit&#233;rios de ecocardiograma na cardiomiopatia chag&#225;sica poderiam ser diferentes dos crit&#233;rios utilizados em outras cardiomiopatias. Isso pode ser observado quando da avalia&#231;&#227;o dos altos valores de m&#233;dias em pacientes com doen&#231;a de Chagas e QRS &lt; 0,12 s.</p>
    <p>Optou-se por incluir pacientes com marca-passo por que eles s&#227;o muito comuns na pr&#225;tica cl&#237;nica e refletem uma importante porcentagem de pacientes com DC. Quando os pacientes sem marca-passo foram analisados, a preval&#234;ncia de dissincronia intraventricular permaneceu alta. A maior limita&#231;&#227;o desse estudo poderia ser a variabilidade do m&#233;todo de avalia&#231;&#227;o da dissincronia. O n&#250;mero de pacientes pode ser uma quest&#227;o, mas os n&#250;meros de eventos cl&#237;nicos s&#227;o altos. Ao final do estudo, foi observado que apenas 8 pacientes n&#227;o apresentavam dissincronia, o que levou &#224; um poder estat&#237;stico menor do que o anteriormente calculado. Al&#233;m disso, ele reflete um grupo selecionado de pacientes Chag&#225;sicos com a forma avan&#231;ada da doen&#231;a, com fortes marcadores progn&#243;sticos, n&#227;o refletindo a popula&#231;&#227;o chag&#225;sica como um todo. Entretanto, esses resultados podem ter implica&#231;&#245;es terap&#234;uticas, como mencionado anteriormente.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Em conclus&#227;o, os pacientes com cardiomiopatia chag&#225;sica apresentam alta preval&#234;ncia de dissincronia intraventricular e moderada preval&#234;ncia interventricular. A alta preval&#234;ncia independe da largura do QRS e continua alta no subgrupo sem marca-passo.</p>
    <p>Nesse grupo de pacientes selecionados com cardiomiopatia chag&#225;sica, n&#227;o observamos o valor progn&#243;stico da dissincronia ventricular. Estudos mais amplos s&#227;o necess&#225;rios para melhor investigar essa quest&#227;o.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Jussara de Oliveira Pinheiro Duarte pela Escola Bahiana de Medicina e Sa&#250;de P&#250;blica - Funda&#231;&#227;o Bahiana para o Desenvolvimento da Ci&#234;ncia.</p>
    <p>
      <fn id="back" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Luis Cl&#225;udio Lemos Correia </p>
        <p> Av. Princesa Leopoldina, 19/402 </p>
        <p> 40150-080 - Salvador, BA - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="lccorreia@terra.com.br">lccorreia@terra.com.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 01/05/10; revisado recebido em 02/09/10; aceito em 21/09/10.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. World Health    Organization. Control of Chagas' diseases: second report of the WHO Expert Comitee.    Geneva; 2002 (Technical Report Series 905).</mixed-citation>
        <element-citation publication-type="book">
          <source>Control of Chagas' diseases: second report of the WHO Expert Comitee</source>
          <date>
            <year>2002</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Marin-Neto JA,    Sim&#245;es MA, Sarabanda AVL. Cardiopatia chag&#225;sica. Arq Bras Cardiol.    1999;72(3):247-63.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiopatia chag&#225;sica</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>247</fpage>
          <lpage>63</lpage>
          <issue>3</issue>
          <volume>72</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Marin-Neto</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Sim&#245;es</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Sarabanda</surname>
              <given-names>AVL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Rassi Jr A,    Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation    of a risk score for predicting death in Chagas' heart disease. N Engl J Med.    2006;355(8):799-808.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Development and validation of a risk score for predicting death in Chagas' heart disease</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>799</fpage>
          <lpage>808</lpage>
          <issue>8</issue>
          <volume>355</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rassi Jr</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rassi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Xavier</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Rassi</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Rassi</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Bader H, Garrigue    S, Lafitte S, Reuter S, Jais P, Haissaguerre M, et al. Intra-left ventricular    electromechanical asynchrony: a new independent predictor of severe cardiac    events in heart failure patients. J Am Cardiol. 2004;43(2):248-56.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Intra-left ventricular electromechanical asynchrony: a new independent predictor of severe cardiac events in heart failure patients</article-title>
          <source>J Am Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>248</fpage>
          <lpage>56</lpage>
          <issue>2</issue>
          <volume>43</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bader</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Garrigue</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lafitte</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Reuter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jais</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Haissaguerre</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Fauchier L,    Marie O, Casset-Senon D, Babuty D, Cosnay P, Fauchier JP. Interventricular and    intraventricular dyssynchrony in idiopathic dilated cardiomyopathy: a prognostic    study with fourier phase analysis of radionuclide angiocintigraphy. J Am Coll    Cardiol. 2002;40(11):2022-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy: a prognostic study with fourier phase analysis of radionuclide angiocintigraphy</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>2022</fpage>
          <lpage>30</lpage>
          <issue>11</issue>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fauchier</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Marie</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Casset-Senon</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Babuty</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cosnay</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fauchier</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Cho GY, Song    JK, Park WJ, Han SW, Choi SH, Doo YC, et al. Mechanical dyssynchrony assessed    by tissue Doppler imaging is a powerful predictor of mortality in congestive    heart failure with normal QRS. J Am Cardiol. 2005;46(12):2237-43.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mechanical dyssynchrony assessed by tissue Doppler imaging is a powerful predictor of mortality in congestive heart failure with normal QRS</article-title>
          <source>J Am Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2237</fpage>
          <lpage>43</lpage>
          <issue>12</issue>
          <volume>46</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cho</surname>
              <given-names>GY</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Doo</surname>
              <given-names>YC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Chung ES, Leon    AR, Tavazzi L, Sun J-P, Nihoyannopoulos P, Merlino J, et al. Result of the predictors    of response to CRT (PROSPECT) trial. Circulation. 2008;117(20):2608-16.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Result of the predictors of response to CRT (PROSPECT) trial</article-title>
          <source>Circulation</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>2608</fpage>
          <lpage>16</lpage>
          <issue>20</issue>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Leon</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Tavazzi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>J-P</given-names>
            </name>
            <name>
              <surname>Nihoyannopoulos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Merlino</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Yu CM, Fung    WH, Lin H, Zhang Q, Sanderson JE, Lau SP. Predictors of left ventricular reverse    remodeling after cardiac resynchronization therapy for heart failure secondary    to idiopathic dialed or ischemic cardiomyophaty. Am J Cardiol. 2003;91(6):684-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dialed or ischemic cardiomyophaty</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>684</fpage>
          <lpage>8</lpage>
          <issue>6</issue>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Fung</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Sanderson</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Yu CM, Fung    WH, Chan CK, Chan YS, Zhang Q, Lin H, et al. Comparison of efficacy of reverse    remodeling and clinical improvement for relatively narrow and wide QRS complexes    after cardiac resynchronization therapy for heart failure. J Cardiovasc Electrophysiol.    2004;15(9):1058-65.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1058</fpage>
          <lpage>65</lpage>
          <issue>9</issue>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Fung</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Yu CM, Fung    WH, Zhang Q, Chan CK, Chan YS, Lin H, et al. Tissue Doppler imaging is superior    to strain rate imaging and postsystolic shortening on the prediction of reverse    remodelling in both ischemic and non-ischemic heart failure after cardiac resynchronization    therapy. Circulation. 2004;110(1):66-73.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodelling in both ischemic and non-ischemic heart failure after cardiac resynchronization therapy</article-title>
          <source>Circulation</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>66</fpage>
          <lpage>73</lpage>
          <issue>1</issue>
          <volume>110</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Fung</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Yu CM, Bax    JJ, Gorcsan J 3rd. Critical appraisal of methods to assess mechanical dyssynchrony.    Curr Opin Cardiol. 2009;24(1):18-28.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Critical appraisal of methods to assess mechanical dyssynchrony</article-title>
          <source>Curr Opin Cardiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>18</fpage>
          <lpage>28</lpage>
          <issue>1</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Bax</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Gorcsan</surname>
              <given-names>J 3rd.</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Bax JJ, Marwick    TH, Molhoek SG, Bleeker JB, Van Erven L, Boersma E, et al. Left ventricular    dyssynchrony predicts benefit of cardiac resynchronization therapy in patients    with end stage heart failure before pacemaker implantation. Am J Cardiol. 2003;92(10):1238-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end stage heart failure before pacemaker implantation</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1238</fpage>
          <lpage>40</lpage>
          <issue>10</issue>
          <volume>92</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bax</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Marwick</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Molhoek</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Bleeker</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Van Erven</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Boersma</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Zamorano J,    P&#233;res de Isla LP, Roque C, Khanhderia RC. The role of echocardiography    in the assessment of mechanical dyssynchrony and its importance in predicting    response to prognosis after cardiac resynchronization therapy. J Am Soc Echocardiogr.    2007;20(1):91-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The role of echocardiography in the assessment of mechanical dyssynchrony and its importance in predicting response to prognosis after cardiac resynchronization therapy</article-title>
          <source>J Am Soc Echocardiogr</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>91</fpage>
          <lpage>9</lpage>
          <issue>1</issue>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Zamorano</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>P&#233;res de Isla</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Roque</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Khanhderia</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Haghjoo M,    Bagherzadeh A, Farahani MM, Haghighi ZO, Sadr-Ameli MA. Significance of QRS    morphology in determining the prevalence of mechanical dyssynchrony in heart    failure patient eligible for cardiac resynchronization: particular focus on    patients with right bundle block with and without coexistent left-sided conduction    defects. Europace. 2008;10(5):566-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Significance of QRS morphology in determining the prevalence of mechanical dyssynchrony in heart failure patient eligible for cardiac resynchronization: particular focus on patients with right bundle block with and without coexistent left-sided conduction defects</article-title>
          <source>Europace</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>566</fpage>
          <lpage>71</lpage>
          <issue>5</issue>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Haghjoo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bagherzadeh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Farahani</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Haghighi</surname>
              <given-names>ZO</given-names>
            </name>
            <name>
              <surname>Sadr-Ameli</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Rochitte CE,    Nacif MS, Oliveira Junior AC, Siqueira-Batista R, Marchiori E, Uellendahl M,    et al. Cardiac magnetic resonance in Chagas' disease. Artif Organs. 2007;31(4):259-67.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac magnetic resonance in Chagas' disease</article-title>
          <source>Artif Organs</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>259</fpage>
          <lpage>67</lpage>
          <issue>4</issue>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rochitte</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Nacif</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Oliveira Junior</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Siqueira-Batista</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Marchiori</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Uellendahl</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Rochitte CE,    Oliveira PF, Andrade JM, Ianni BM, Parga JR, &#193;vila LF, et al. Myocardial    delayed enhancement by magnetic resonance imaging in patients with Chagas disease:    a marker of disease severity. J Am Coll Cardiol. 2005;46(8):1553-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas disease: a marker of disease severity</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1553</fpage>
          <lpage>8</lpage>
          <issue>8</issue>
          <volume>46</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rochitte</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Andrade</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ianni</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Parga</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>&#193;vila</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Haghjoo M,    Bagherzadeh A, Fazelifar AF, Haghighi ZO, Esmaielzadeh M, Alisadeh A, et al.    Prevalence of mechanical dyssynchrony in heart failure patients with different    QRS durations. Pacing Clin Electrophysiol. 2007;30(5):616-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of mechanical dyssynchrony in heart failure patients with different QRS durations</article-title>
          <source>Pacing Clin Electrophysiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>616</fpage>
          <lpage>22</lpage>
          <issue>5</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Haghjoo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bagherzadeh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fazelifar</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Haghighi</surname>
              <given-names>ZO</given-names>
            </name>
            <name>
              <surname>Esmaielzadeh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alisadeh</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Bleeker GB,    Kaandorp TAM, Lamb HJ, Boersma E, Steendijk P, Roos A, et al. Effects of posterolateral    scar tissue on clinical and echocardiographic improvement after cardiac resynchronization    therapy. Circulation. 2006;113(7):969-76.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy</article-title>
          <source>Circulation</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>969</fpage>
          <lpage>76</lpage>
          <issue>7</issue>
          <volume>113</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bleeker</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Kaandorp</surname>
              <given-names>TAM</given-names>
            </name>
            <name>
              <surname>Lamb</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Boersma</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Steendijk</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Roos</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Ypenburg C,    Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, et al.    Impact of viability and scar tissue on response to cardiac resynchronization    therapy in ischaemic heart failure patients. Eur Heart J. 2007;28(1):33-41.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>33</fpage>
          <lpage>41</lpage>
          <issue>1</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ypenburg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schalij</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Bleeker</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Steendijk</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Boersma</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dibbets-Schneider</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Cleland JGF,    Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect    of cardiac resynchronization on morbidity and mortality in heart failure (CARE-HF).    N Engl J Med. 2005;352(15):1539-49.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The effect of cardiac resynchronization on morbidity and mortality in heart failure (CARE-HF)</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1539</fpage>
          <lpage>49</lpage>
          <issue>15</issue>
          <volume>352</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cleland</surname>
              <given-names>JGF</given-names>
            </name>
            <name>
              <surname>Daubert</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Erdmann</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Freemantle</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gras</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kappenberger</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Cleland JGF,    Freemantle N, Ghio S, Fruhwald F, Shankar A, Marijanowski M, et al. Predicting    the long-term effects of cardiac resynchronization therapy on mortality from    baselines variables and the early response: a report from the CARE-HF Trial.    J Am Coll Cardiol. 2008;52(6):438-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Predicting the long-term effects of cardiac resynchronization therapy on mortality from baselines variables and the early response: a report from the CARE-HF Trial</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>438</fpage>
          <lpage>45</lpage>
          <issue>6</issue>
          <volume>52</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cleland</surname>
              <given-names>JGF</given-names>
            </name>
            <name>
              <surname>Freemantle</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ghio</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fruhwald</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Shankar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Marijanowski</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Bristow MR,    Saxon MD, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization    therapy with and without an implantable defibrillator in advanced chronic heart    failure(COMPANION). N Engl J Med. 2004;350(21):2140-550.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac-resynchronization therapy with and without an implantable defibrillator in advanced chronic heart failure(COMPANION)</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>2140</fpage>
          <lpage>550</lpage>
          <issue>21</issue>
          <volume>350</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bristow</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Saxon</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Boehmer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Krueger</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kass</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>De Marco</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Anand IS, Carson    P, Galle E, Song R, Boehmer J, Ghali JK, et al. Cardiac resyncronization therapy    reduces the risk of hospitalization in patients with advanced heart failure:    results from COMPANION trial. Circulation 2009;119(7):969-77.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac resyncronization therapy reduces the risk of hospitalization in patients with advanced heart failure: results from COMPANION trial</article-title>
          <source>Circulation</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>969</fpage>
          <lpage>77</lpage>
          <issue>7</issue>
          <volume>119</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Anand</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Carson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Galle</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Boehmer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ghali</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Silva RT, Martinelli    FM, Lima CEB, Daniela GMC, Nishi&#243;ka SAD, Pedrosa AA, et al. Functional    behavior of patients with conventional pacemaker undergoing cardiac resynchronization.    Arq Bras Cardiol. 2008;90(2):138-43.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Functional behavior of patients with conventional pacemaker undergoing cardiac resynchronization</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>138</fpage>
          <lpage>43</lpage>
          <issue>2</issue>
          <volume>90</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Martinelli</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>CEB</given-names>
            </name>
            <name>
              <surname>Daniela</surname>
              <given-names>GMC</given-names>
            </name>
            <name>
              <surname>Nishi&#243;ka</surname>
              <given-names>SAD</given-names>
            </name>
            <name>
              <surname>Pedrosa</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Bax JJ, Gorcsan    J. Echocardiography and noninvasive imaging in cardiac resynchronization therapy:    Results of the PROSPECT study in perspective. J Am Coll Cardiol. 2009;53(21):1933-43.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Echocardiography and noninvasive imaging in cardiac resynchronization therapy: Results of the PROSPECT study in perspective</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>1933</fpage>
          <lpage>43</lpage>
          <issue>21</issue>
          <volume>53</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bax</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Gorcsan</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Prevalencia y valor pron&#243;stico de la disincron&#237;a ventricular en la miocardiopat&#237;a chag&#225;sic</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: La miocardiopat&#237;a chag&#225;sica es una causa importante de insuficiencia card&#237;aca en Am&#233;rica Latina. La disincron&#237;a ventricular puede ser un factor de descompensaci&#243;n en el curso de la enfermedad, pero todav&#237;a no hay datos sobre su prevalencia e implicaciones pron&#243;sticas importantes. OBJETIVO:Describir la prevalencia y valores pron&#243;sticos de la disincron&#237;a ventricular en la miocardiopat&#237;a chag&#225;sica. M&#201;TODOS:56 pacientes con cardiomiopat&#237;a chag&#225;sica se seleccionaron de forma consecutiva en dos pruebas serol&#243;gicas positivas y una fracci&#243;n de eyecci&#243;n (FE) &lt; 45% en el ecocardiograma. El ecocardiograma evalu&#243; la presencia de disincron&#237;a intraventricular usando tres criterios y disincron&#237;a interventricular con un criterio. Los pacientes fueron seguidos durante 21 &#177; 14 meses, y los eventos card&#237;acos se definen como la combinaci&#243;n de muerte y hospitalizaci&#243;n. RESULTADOS:La media de edad de la poblaci&#243;n fue de 56 &#177; 10 a&#241;os, y el 50% hombres era del sexo masculino. La fracci&#243;n de eyecci&#243;n (FE) media fue de 30 &#177; 8% y el 87% de los pacientes ten&#237;a clase funcional I/II (NYHA). La prevalencia de disincron&#237;a interventricular fue del 34% (IC 95%: 22%-48%) y la disincron&#237;a intraventricular ten&#237;a una prevalencia del 85% (IC 95%: 75%-93%). La prevalencia de disincron&#237;a intraventricular era similar en pacientes con duraci&#243;n del QRS &lt; 0,12 s &#243; &gt; 0,12 s (85% y 89% respectivamente, p = 0,66). Veinte eventos se registraron. La incidencia de eventos combinados fue similar en pacientes con o sin la disincron&#237;a intraventricular (35% versus 38%, p = 0,9) y aquellos con o sin la disincron&#237;a interventricular (39% versus 34%, p = 0,73). CONCLUSI&#211;N:Pacientes con miocardiopat&#237;a chag&#225;sica tienen alta prevalencia de disincron&#237;a intraventricular y moderada prevalencia de disincron&#237;a interventricular. La alta prevalencia independiente de la anchura del QRS. La disincron&#237;a ventricular no tiene alg&#250;n valor pron&#243;stico en pacientes con miocardiopat&#237;a chag&#225;sica.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Disincron&#237;a</kwd>
        <kwd>miocardiopat&#237;a chag&#225;sica</kwd>
        <kwd>enfermedad de Chagas</kwd>
        <kwd>pron&#243;stico</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Prevalencia y valor pron&#243;stico de la disincron&#237;a ventricular en la miocardiopat&#237;a chag&#225;sica</bold>
          </label>
          <p>
            <bold>Jussara de Oliveira Pinheiro Duarte<sup>I, II</sup>; Luiz Pereira de Magalh&#227;es<sup>II</sup>; Oto Oliveira Santana<sup>II</sup>; Leandro Barros da Silva<sup>I</sup>; Monique Sim&#245;es<sup>II</sup>; Darluce Oliveira de Azevedo<sup>II</sup>; Oct&#225;vio Alencar Barbosa J&#250;nior<sup>II</sup>; Alexsandro Alves Fagundes<sup>II</sup>; Francisco Jos&#233; Farias Borges dos Reis<sup>II</sup>; Luis Cl&#225;udio Lemos Correia<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Escola Bahiana de Medicina e Sa&#250;de P&#250;blica, Salvador, BA - Brasil</p>
      <p><sup> II</sup>Hospital Universit&#225;rio Professor Edgar Santos - UFBA, Salvador, BA - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO: </bold>La miocardiopat&#237;a chag&#225;sica es una causa importante de insuficiencia card&#237;aca en Am&#233;rica Latina. La disincron&#237;a ventricular puede ser un factor de descompensaci&#243;n en el curso de la enfermedad, pero todav&#237;a no hay datos sobre su prevalencia e implicaciones pron&#243;sticas importantes.</p>
      <p><bold>OBJETIVO:</bold>Describir la prevalencia y valores pron&#243;sticos de la disincron&#237;a ventricular en la miocardiopat&#237;a chag&#225;sica.</p>
      <p><bold>M&#201;TODOS:</bold>56 pacientes con cardiomiopat&#237;a chag&#225;sica se seleccionaron de forma consecutiva en dos pruebas serol&#243;gicas positivas y una fracci&#243;n de eyecci&#243;n (FE) &lt; 45% en el ecocardiograma. El ecocardiograma evalu&#243; la presencia de disincron&#237;a intraventricular usando tres criterios y disincron&#237;a interventricular con un criterio. Los pacientes fueron seguidos durante 21 &#177; 14 meses, y los eventos card&#237;acos se definen como la combinaci&#243;n de muerte y hospitalizaci&#243;n.</p>
      <p><bold>RESULTADOS:</bold>La media de edad de la poblaci&#243;n fue de 56 &#177; 10 a&#241;os, y el 50% hombres era del sexo masculino. La fracci&#243;n de eyecci&#243;n (FE) media fue de 30 &#177; 8% y el 87% de los pacientes ten&#237;a clase funcional I/II (NYHA). La prevalencia de disincron&#237;a interventricular fue del 34% (IC 95%: 22%-48%) y la disincron&#237;a intraventricular ten&#237;a una prevalencia del 85% (IC 95%: 75%-93%). La prevalencia de disincron&#237;a intraventricular era similar en pacientes con duraci&#243;n del QRS &lt; 0,12 s &#243; &gt; 0,12 s (85% y 89% respectivamente, p = 0,66). Veinte eventos se registraron. La incidencia de eventos combinados fue similar en pacientes con o sin la disincron&#237;a intraventricular (35% <italic>versus</italic> 38%, p = 0,9) y aquellos con o sin la disincron&#237;a interventricular (39% <italic>versus</italic> 34%, p = 0,73).</p>
      <p><bold>CONCLUSI&#211;N:</bold>Pacientes con miocardiopat&#237;a chag&#225;sica tienen alta prevalencia de disincron&#237;a intraventricular y moderada prevalencia de disincron&#237;a interventricular. La alta prevalencia independiente de la anchura del QRS. La disincron&#237;a ventricular no tiene alg&#250;n valor pron&#243;stico en pacientes con miocardiopat&#237;a chag&#225;sica.</p>
      <p><bold>Palabras clave: </bold>Disincron&#237;a, miocardiopat&#237;a chag&#225;sica, enfermedad de Chagas, pron&#243;stico.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>Actualmente se estima que entre 10 y 18 millones de personas est&#225;n infectadas con la Enfermedad de Chagas (EC) en Am&#233;rica Latina<sup>1</sup>. La mortalidad a causa de la miocardiopat&#237;a chag&#225;sica est&#225; &#237;ntimamente relacionada al grado de compromiso mioc&#225;rdico<sup>2</sup>. Adem&#225;s de ello, el riesgo de muerte no es el mismo para todos los pacientes y muchos autores vienen tratando de identificar las caracter&#237;sticas cl&#237;nicas que se&#241;alen a los pacientes con mayor riesgo. Recientemente, Rassi et al<sup>3</sup> publicaron una puntuaci&#243;n de riesgo con una precisi&#243;n pron&#243;stica, teniendo en cuenta el sexo, el bajo voltaje en el ecocardiograma, la cardiomegalia en la radiograf&#237;a de t&#243;rax, taquicardia ventricular no sostenida, la clase funcional y la fracci&#243;n de eyecci&#243;n reducida en el electrocardiograma. Adem&#225;s de la cuantificaci&#243;n del grado de disfunci&#243;n ventricular, el ecocardiograma ha surgido recientemente como una herramienta para determinar la presencia de disincron&#237;a ventricular, que se relaciona con un peor pron&#243;stico en las miocardiopat&#237;as debido a otras etiolog&#237;as<sup>4-6</sup>. El valor pron&#243;stico de la disincron&#237;a ventricular en pacientes con miocardiopat&#237;a chag&#225;sica no es conocido. Recientemente, un controvertido estudio denominado PROSPECT ha descrito el valor y la alta variabilidad inter-observador del ecocardiograma en el an&#225;lisis de la disincron&#237;a, y ello es un tema que se analiza en este estudio con pacientes chag&#225;sicos<sup>7</sup>. Dada la necesidad de nuevos marcadores de riesgo en esta enfermedad que puedan a&#241;adir valor pron&#243;stico al score de Rassi y la falta de datos sobre la prevalencia de disincron&#237;a ventricular en esta poblaci&#243;n, evaluamos la disincron&#237;a por ecocardiograma en 56 individuos con miocardiopat&#237;a chag&#225;sica, que se siguieron por 21 &#177; 14 meses.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>
        <bold>Poblaci&#243;n del estudio</bold>
      </p>
      <p>El estudio se llev&#243; a cabo en la Cl&#237;nica de Miocardiopat&#237;a en la Universidad Federal de Bah&#237;a. La miocardiopat&#237;a chag&#225;sica fue definida como dos pruebas serol&#243;gicas positivas para la Enfermedad de Chagas (inmunofluorescencia y hemaglutinaci&#243;n) y la fracci&#243;n de eyecci&#243;n (FE) &lt; 45% en el ecocardiograma. Los nuevos pacientes con estas caracter&#237;sticas fueron seleccionados de forma consecutiva desde junio 2005 a agosto de 2008. El estudio fue aprobado por el Comit&#233; de &#201;tica local. Todos los pacientes firmaron un Formulario de Consentimiento Informado. Se excluy&#243; a los pacientes con condiciones card&#237;acas asociadas con (cardiopat&#237;a hipertensiva, valvar o isqu&#233;mica). Se excluy&#243; a los pacientes con fibrilaci&#243;n auricular o extras&#237;stoles frecuentes debido a que estas arritmias pueden afectar la evaluaci&#243;n de la disincron&#237;a mediante el ecocardiograma.</p>
      <p>
        <bold>Protocolo del estudio</bold>
      </p>
      <p>Se emple&#243; un sistema de ultrasonido disponible comercialmente (Vingmed system FiVi/Seven, General Electric- Vingmed, Milwaukee, WI, EE.UU.). Las im&#225;genes fueron obtenidas con un transductor de 3,5 MHz a una profundidad de 16 cm en los cortes paraesternal y apical. Los par&#225;metros del Doppler tisular se midieron a partir de im&#225;genes en color de tres latidos del coraz&#243;n consecutivos, mediante el an&#225;lisis <italic>off-line</italic>. El observador no ten&#237;a conocimiento de la condici&#243;n cl&#237;nica de los pacientes. La disincron&#237;a intraventricular fue definida por los siguientes criterios: 1) desviaci&#243;n est&#225;ndar (DE) de la demora entre el inicio de la onda R en el electrocardiograma y la velocidad pico de la onda S medida en 12 segmentos del ventr&#237;culo izquierdo &gt; 33 ms<sup>8-10</sup>, 2) intervalo m&#225;ximo (IM), medido entre 2 segmentos cualesquiera &gt; 100 ms<sup>11</sup>; 3) demora entre los segmentos septo-basal y basal-lateral (SLD) &gt; 60 ms<sup>12</sup>. Para disincron&#237;a interventricular, se utiliz&#243; el Doppler pulsado. Se determin&#243; como la diferencia en los intervalos de tiempo de la onda Q hasta el inicio del flujo en la arteria pulmonar, en comparaci&#243;n con lo intervalo de tiempo de la onda Q hasta el comienzo del flujo a&#243;rtico, respectivamente. Un valor &gt; 40 ms es considerado anormal<sup>13</sup>. La FE se calcul&#243; a trav&#233;s del m&#233;todo de Simpson modificado. Adem&#225;s de ello, un registro Holter de 24 horas se llev&#243; a cabo en todos los pacientes. La puntuaci&#243;n de Rassi se calcul&#243; como previamente validado<sup>3</sup>. Resumidamente, ese score tiene en cuenta el sexo, el bajo voltaje en el electrocardiograma, la cardiomegalia en el rayo-X de t&#243;rax, la taquicardia ventricular no sostenida, la clase funcional III/IV y la FE reducida en el ecocardiograma.</p>
      <p>Los pacientes fueron controlados de forma regular, cada 3 meses, por consultas en la cl&#237;nica y llamadas telef&#243;nicas. Los eventos cl&#237;nicos tales como la muerte total, la muerte cardiovascular y la hospitalizaci&#243;n por insuficiencia card&#237;aca o arritmias se registraron.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>La frecuencia relativa de disincron&#237;a intraventricular e interventricular se describi&#243; con un intervalo de confianza del 95%. Para identificar los factores predictivos en el an&#225;lisis univariado, los datos cl&#237;nicos, ecocardiogr&#225;ficos, incluidos los criterios de disincron&#237;a, se compararon entre los pacientes con y sin eventos. Las variables categ&#243;ricas fueron comparadas usando la Prueba de Chi-cuadrado de Pearson y las variables num&#233;ricas mediante la prueba <italic>t</italic> de <italic>Student</italic> o la prueba de Mann-Whitney; las variables asociadas a los eventos (p <underline>&lt; </underline>0,10) se incluyeron en el an&#225;lisis de regresi&#243;n log&#237;stica para evaluar los predictores independientes. El score de Rassi se eligi&#243; en lugar de los predictores independientes. Basado en un estudio piloto de 28 personas, donde hab&#237;a una prevalencia del 70% de disincron&#237;a, 56 sujetos fueron considerados como suficientes, debido a un equ&#237;voco de precisi&#243;n de &#177; 12% e intervalo de confianza del 95%. En cuanto al valor pron&#243;stico, basado en el estudio de Rassi et al. para definir los factores pron&#243;sticos independientes en DC y en caso de eventos combinados, se estim&#243; un riesgo absoluto de 40%. Por lo tanto, 56 pacientes tambi&#233;n fueron considerados insuficientes, de los cuales 39 presentaron disincron&#237;a y 17 no ten&#237;an disincron&#237;a. Para el grupo con disincron&#237;a, este riesgo alcanza el 60% y para el grupo sin disincron&#237;a, este riesgo ser&#237;a del 20%. El poder del 80% y un alfa del 5% fueron datos del estudio. En el an&#225;lisis de variabilidad intra-observador e inter-observador, el coeficiente de variabilidad (CV) se calcul&#243; entre las medidas en cuanto a los criterios de disincron&#237;a intraventricular e interventricular. Para este an&#225;lisis, aproximadamente el 10% de la muestra se utiliz&#243; un total de 6 pacientes, con dos observadores durante los &#250;ltimos seis pacientes del estudio. Un valor de p &lt; 0,05 fue considerado significativo. El <italic>software</italic> de SPSS 14.0 para Windows (<italic>SPSS Inc., Chicago, II</italic>) se utiliz&#243; para el an&#225;lisis estad&#237;stico.</p>
      <p>No hubo relaciones financieras o personales entre los autores y otras personas u organizaciones que puedan influir en sus acciones de manera inapropiada.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>
        <bold>Caracter&#237;sticas basales</bold>
      </p>
      <p>Un grupo de 56 pacientes con miocardiopat&#237;a chag&#225;sica fueron estudiados, con una edad media 56 &#177; 10 a&#241;os (36 a 79 a&#241;os), y 50% hombres, 82% de ascendencia africana. Hab&#237;an sido tratados de manera efectiva con relaci&#243;n a la presi&#243;n arterial, frecuencia card&#237;aca, funci&#243;n renal y los electrolitos. En general, los pacientes se estaban sometiendo a tratamiento m&#233;dico con inhibidores de la enzima convertidora de la angiotensina, betabloqueantes y bloqueantes de aldosterona, con el 93% de uso regular de medicamentos y el 87% ten&#237;an clase funcional I/II. Esta buena clase funcional se puede explicar por la cl&#237;nica espec&#237;fica (Cl&#237;nica de Miocardiopat&#237;a), con diferentes profesionales de la salud y el uso regular de medicamentos. Un n&#250;mero significativo de los pacientes eran portadores de marcapasos (25%), el 23% ten&#237;a bloqueo de rama derecha y el 14% ten&#237;a bloqueo de rama izquierda. El grado de disfunci&#243;n ventricular izquierda era severo, medido por la fracci&#243;n de eyecci&#243;n del ventr&#237;culo izquierdo de 30 &#177; 8%. Las cavidades se presentaron dilatadas, con una media de di&#225;metro ventricular diast&#243;lico de 66 &#177; 8 mm. Disturbios segmentarios de la contractilidad ventricular eran muy comunes en esta poblaci&#243;n (73%) y el segmento m&#225;s com&#250;nmente afectado era el segmento posterior (56%). Estas caracter&#237;sticas est&#225;n detalladas en la <xref ref-type="table" rid="t1-body2">Tabla 1</xref>.</p>
      <table-wrap id="t1-body2">
        <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt01-es.jpg"/></table-wrap>
      <p>
        <bold>Prevalencia de disincron&#237;a</bold>
      </p>
      <p>Cuando cualesquier de los 3 criterios se tuvieron en cuenta, una prevalencia significativa del 85% (IC del 95%: 75%-93%) de disincron&#237;a intraventricular se observ&#243;. Con base en la desviaci&#243;n est&#225;ndar de 12 segmentos en forma aislada, tuvieron una prevalencia del 75% (IC 95%: 62%-86%), el criterio de intervalo m&#225;ximo estuvo presente en el 79% (IC 95%: 65%-88%) y el retraso septo-lateral, en menor medida, el 48% (IC 95%: 35%-62%). La prevalencia de disincron&#237;a interventricular fue del 34% (IC 95%: 22%-48%) <bold>-</bold> <xref ref-type="table" rid="t2-body2">Tabla 2</xref>. La disincron&#237;a intraventricular permaneci&#243; alta independiente de la anchura del QRS. Estaba presente en el 89% (IC95%. 74%-97%) de los pacientes con QRS &gt; 0,12 s y en el 84% (IC95%: 62%-96%) de los pacientes con QRS &lt; 0,12 s (p = 0,66) - <xref ref-type="table" rid="es_aop02411t03-body2">Tabla 3</xref>. Cuando los tres criterios se analizaban separadamente, ninguna diferencia significativa se observ&#243; con relaci&#243;n al porcentaje, teniendo en cuenta la anchura del QRS en los dos grupos - desviaci&#243;n-est&#225;ndar - 81% <italic>vs</italic> 70% (p = 0,31), intervalo m&#225;ximo - 81% <italic>vs</italic> 75% (p = 0,85) y retraso septo-lateral - 47% <italic>vs</italic> 50% (p = 0,78). La disincron&#237;a interventricular era similar entre los subgrupos de QRS &lt; &#243; &gt; 0,12 s (15% <italic>vs</italic> 44%, p = 0,30). La <xref ref-type="table" rid="es_aop02411t03-body2">Tabla 3</xref> detalla la media de los 4 criterios y valores de p. Cuando comparado el porcentaje, no hubo diferencia. Sin embargo cuando se compararon las medias, el valor fue significativo en el criterio de la desviaci&#243;n est&#225;ndar (p = 0,03) y la diferencia casi significativa en el criterio de VE-VD (p = 0,052).</p>
      <p content-type="asset">
        <table-wrap id="es_aop02411t03-body2">
          <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt02-es.jpg"/></table-wrap>
      </p>
      <table-wrap id="t2-body2">
        <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt03-es.jpg"/></table-wrap>
      <p>En el momento de la evaluaci&#243;n de la disincron&#237;a, todos los pacientes con marcapaso presentaban estimulaci&#243;n ventricular, con un electrodo ventricular en el &#225;pex del VD. En comparaci&#243;n con los pacientes portadores de marcapaso, la disincron&#237;a intraventricular no present&#243; diferencia cuando los porcentajes y las medias se compararon (p = 0,09). Sin embargo, con relaci&#243;n a la disincron&#237;a interventricular, hubo diferencia cuando se compararon los porcentajes (57% <italic>vs</italic> 24%, p = 0,04), y las medias (26 &#177; 22 ms <italic>vs</italic> 48 &#177; 33 ms, p = 0,007). Cuando los pacientes sin marcapaso (n = 42) se analizaron, la prevalencia de disincron&#237;a intraventricular fue del 90% y la disincron&#237;a interventricular fue del 24%, lo que podr&#237;a explicar estos resultados.</p>
      <p>Otra observaci&#243;n es que los trastornos segmentarios de la contractilidad ventricular fueron significativamente m&#225;s prevalentes en los pacientes con disincron&#237;a intraventricular cuando comparados con el grupo sin disincron&#237;a (81% <italic>versus</italic> 57%, p = 0,01). Los trastornos segmentarios de contractilidad ventricular fueron un predictor de disincron&#237;a intraventricular (an&#225;lisis multivariado, p = 0,01).</p>
      <p>
        <bold>Valor pron&#243;stico de la disincron&#237;a</bold>
      </p>
      <p>Durante un per&#237;odo de seguimiento de 21 &#177; 14 meses, se registraron 20 eventos (11 muertes y 9 hospitalizaciones). La incidencia de eventos combinados entre pacientes con y sin disincron&#237;a intraventricular era similar (35% <italic>vs</italic> 38%, p = 0,9). Cuando solo se tuvieron en cuenta las muertes, la incidencia fue del 19% y el 25%, respectivamente (p = 0,68). En el an&#225;lisis de la presencia o ausencia de disincron&#237;a interventricular, la incidencia de eventos fue del 39% y el 34%, respectivamente (p = 0,73). Cuando solamente las muertes se tuvieron en cuenta, la incidencia era del 28% comparada con el 16% en pacientes sin disincron&#237;a (p=0,29).</p>
      <p>En el an&#225;lisis univariado, las siguientes variables eran prevalentes en individuos con eventos cuando comparados a los que est&#225;n libres de eventos: clase funcional III / IV (30% <italic>vs</italic> 6%, p = 0,02), &#237;ndice cardiotor&#225;cico &gt; 50% (70% <italic>vs</italic> 36%, p = 0,02). La media del score de Rassi era m&#225;s alta en pacientes con eventos (8) cuando comparada con los pacientes remanentes (6, p = 0,01) y la FE era m&#225;s baja en pacientes con eventos (27% &#177; 7% <italic>vs</italic> 32% &#177; 8%, p = 0,02). Cuando examinamos los cuatro criterios para disincron&#237;a, el retraso septo-lateral y la diferencia VD-VE mostraron un valor de p = 0,10 (<xref ref-type="table" rid="t4-body2">Tabla 4</xref>).</p>
      <table-wrap id="t4-body2">
        <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt04-es.jpg"/></table-wrap>
      <p>El an&#225;lisis multivariado por regresi&#243;n log&#237;stica mostr&#243; que el score de Rassi fue el &#250;nico predictor de eventos combinados (<italic>odds ratio</italic> - <italic>OR</italic>-1.19; IC95%: 1,02 a 1,40, p=0,01). Las variables de disincron&#237;a - retraso septo-lateral (intraventricular) y diferencia VD-VE (interventricular) no fueron significantes- retraso septo-lateral - OR = 0,98 (IC95%: 0,97-1.00) y diferencia VI-VD -1,01 (IC95%: 0,98 a 1,04) - <xref ref-type="table" rid="t5-body2">Tabla 5</xref>.</p>
      <table-wrap id="t5-body2">
        <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt05-es.jpg"/></table-wrap>
      <p>
        <bold>Variabilidad interobservador e intra-observador</bold>
      </p>
      <p>Para las variables de desviaci&#243;n est&#225;ndar y rango m&#225;ximo, hab&#237;a una baja variabilidad intra-observador (el 9% y el 10% respectivamente) y una variabilidad interobservador moderada (el 23% y el 18% respectivamente). En cuanto al retraso septo-lateral y la diferencia VI-VD, ambas las variabilidades intra-observador e interobservador eran moderadas a altas (23% al 64%). La variabilidad intra-observador (del 9% al 27%) era mucho menor en comparaci&#243;n con la variabilidad interobservador (del 18% al 64%) en cualquiera de las cuatro variables.</p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>Este es el primer estudio para evaluar la prevalencia de la disincron&#237;a ventricular y sus implicaciones cl&#237;nicas en pacientes con miocardiopat&#237;a chag&#225;sica. En primer lugar, observamos que la disincron&#237;a es una condici&#243;n altamente prevalente; y en segundo, la presencia de disincron&#237;a no puede afectar el pron&#243;stico de los pacientes con miocardiopat&#237;a chag&#225;sica.</p>
      <p>La prevalencia del 85% de disincron&#237;a intraventricular se debe considerar como significativamente alta, especialmente cuando se la compara con otras etiolog&#237;as, tales como la miocardiopat&#237;a isqu&#233;mica y dilatada, con una prevalencia relatada del 58% en pacientes con bloqueo de rama izquierda y el 42% en pacientes con bloqueo de la rama derecha asociado con bloqueo divisional<sup>14</sup>. Posibles explicaciones para esta prevalencia m&#225;s alta en pacientes chag&#225;sicos ser&#237;an las alteraciones segmentarias secundarias a las &#225;reas de fibrosis asociadas con el proceso inflamatorio cr&#243;nico y difuso, que es persistente e inherente a esta enfermedad<sup>15,16</sup>. En cuanto a la disincron&#237;a interventricular, nuestros hallazgos fueron similares a aquellos relatados en otras etiolog&#237;as<sup>17</sup>. En esta poblaci&#243;n, ninguna diferencia significativa se observ&#243; con relaci&#243;n a la prevalencia basada en la anchura del QRS, solamente en algunos valores de medias de criterios de disincron&#237;a intraventricular. Con relaci&#243;n al criterio interventricular, esta diferencia fue m&#225;s evidente, pero sin alcanzar significaci&#243;n estad&#237;stica s&#243;lo en los pacientes con marcapasos. En la literatura, la prevalencia de disincron&#237;a intraventricular e interventricular est&#225; relacionada con la anchura del QRS en otras etiolog&#237;as<sup>17</sup>.</p>
      <p>El grado de fibrosis en pacientes con Enfermedad de Chagas (EC) en contradicci&#243;n con los beneficios de la resincronizaci&#243;n, como el referido para miocardiopat&#237;a isqu&#233;mica con &#225;reas de cicatrices transmurales<sup>18,19</sup>. El criterio septo-lateral en esta poblaci&#243;n era menos prevalente, pero no hab&#237;a relaci&#243;n con el &#225;rea de fibrosis. Esta medici&#243;n se realiza en la porci&#243;n anterior, un &#225;rea que normalmente no es afectada por la EC. Por otra parte, todos los dem&#225;s criterios fueron muy frecuentes y podr&#237;an ser un factor a favor de la terapia, ya bien establecida en importantes estudios cl&#237;nicos en otras etiolog&#237;as (CARE-HF y COMPANION)<sup>20-23</sup> y en estudios peque&#241;os en la poblaci&#243;n chag&#225;sica. Silva et al<sup>24</sup> describieron una poblaci&#243;n de 29 pacientes, la mitad de los cuales eran chag&#225;sicos, que recibieron terapia de resincronizaci&#243;n y evolucionaron con mejora cl&#237;nica y de fracci&#243;n de eyecci&#243;n (FE). Estos individuos pueden beneficiarse de la terapia, pero esto no se puede afirmar en este momento y un nuevo estudio cl&#237;nico es necesario para determinar esta cuesti&#243;n.</p>
      <p>Los datos previos refirieron una relaci&#243;n entre la disincron&#237;a y un pron&#243;stico peor en otras miocardiopat&#237;as. Cho et al<sup>6</sup> evaluaron la disincron&#237;a en 106 pacientes con insuficiencia cardiaca y verificaron que la disincron&#237;a era un fuerte predictor de eventos cl&#237;nicos severos<sup>6</sup>. De forma similar, Bader et al<sup>4</sup>, al describir un grupo de 104 pacientes, mostraron que la presencia de disincron&#237;a intraventricular es un factor determinante de eventos card&#237;acos adversos, independientemente de la FE y del QRS<sup>4</sup>. En oposici&#243;n, en el presente estudio, la disincron&#237;a no evidenci&#243; ser un marcador en pacientes con miocardiopat&#237;a chag&#225;sica. Posibles explicaciones pueden ser la alta prevalencia, con casi todos presentando disincron&#237;a, y probablemente la esperada variabilidad del m&#233;todo utilizado para evaluar la disincron&#237;a. Al analizar la exactitud de las mediciones de disincron&#237;a, podemos observar una variabilidad intra-observador m&#225;s baja cuando comparada con la variabilidad interobservador menor. Estas mediciones reflejan, de cierta manera, la alta variabilidad de estos valores, ya bien establecida en la literatura<sup>7-25</sup>. La reciente publicaci&#243;n del estudio PROSPECT evidenci&#243; un bajo valor predictivo del ecocardiograma con relaci&#243;n a la disincron&#237;a Este estudio corriente mostr&#243; un resultado muy similar con respecto a la variabilidad, teniendo en cuenta la misma variable. Adem&#225;s de ello, puede explicar el resultado negativo en relaci&#243;n con el pron&#243;stico. Una sugerencia es que los criterios del ecocardiograma en la miocardiopat&#237;a chag&#225;sica podr&#237;an ser diferentes de los criterios utilizados en otras miocardiopat&#237;as. Esto se puede observar en la evaluaci&#243;n de los altos valores de medias en pacientes con enfermedad de Chagas y QRS &lt; 0,12 s.</p>
      <p>Se decidi&#243; incluir a pacientes con marcapaso, ya que son muy comunes en la pr&#225;ctica cl&#237;nica y reflejan un porcentaje significativo de pacientes con EC. Cuando se analizaron a los pacientes sin marcapaso, la prevalencia de disincron&#237;a intraventricular se mantuvo alta. La principal limitaci&#243;n de este estudio podr&#237;a ser la variabilidad del m&#233;todo de evaluaci&#243;n de la disincron&#237;a. El n&#250;mero de pacientes puede ser un problema, pero el n&#250;mero de eventos cl&#237;nicos son altos. Al final del estudio, se observ&#243; que s&#243;lo 8 pacientes no presentaban disincron&#237;a, lo que llev&#243; a un menor poder estad&#237;stico de lo que se calcul&#243; anteriormente. Por otra parte, refleja un grupo seleccionado de pacientes con enfermedad de Chagas avanzada, con fuertes marcadores de pron&#243;stico, que no reflejan la poblaci&#243;n chag&#225;sica en su conjunto. Sin embargo, estos resultados pueden tener implicaciones terap&#233;uticas, como se mencion&#243; anteriormente.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>En conclusi&#243;n, los pacientes con miocardiopat&#237;a chag&#225;sica tienen una alta prevalencia de disincron&#237;a intraventricular y moderada prevalencia interventricular. La alta prevalencia es independiente de la anchura del QRS y se mantiene alta en el subgrupo sin marcapasos.</p>
      <p>En este grupo de pacientes seleccionados con miocardiopat&#237;a chag&#225;sica, no observamos valor pron&#243;stico de la disincron&#237;a ventricular. Estudios m&#225;s amplios son necesarios para investigar mejor este tema.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de Disertaci&#243;n de Maestr&#237;a de Jussara de Oliveira Pinheiro Duarte, por la <italic>Escola Bahiana de Medicina e Sa&#250;de P&#250;blica - Funda&#231;&#227;o Bahiana para o Desenvolvimento da Ci&#234;ncia</italic>.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Prevalence and prognostic value of ventricular dyssynchrony in chagas cardiomyopathy</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Chagas cardiomyopathy is one important cause of heart failure in Latin America. Ventricular dyssynchrony may be a factor of decompensation in the course of this disease, but there are no data on its prevalence and its main prognostic implications yet. OBJECTIVE: Describe prevalence and prognostic value of ventricular dyssynchrony in Chagas cardiomyopathy. METHODS: 56 patients with Chagas cardiomyopathy were consecutively selected by two positive serologies and an ejection fraction &lt; 45% in the echocardiogram. The echocardiogram evaluated the presence of intraventricular dyssynchrony using 3 criteria and interventricular dyssynchrony using 1 criterion. Patients were followed for 21 &#177; 14 months and cardiac events were defined as the combination of death and hospitalization. RESULTS: The average age of the population was 56 &#177; 10 years, 50% males. Mean ejection fraction was 30 &#177; 8% and 87% presented functional class I/II (NYHA). The prevalence of interventricular dyssynchrony was 34% (95% CI: 22%-48%) and intraventricular dyssynchrony had a prevalence of 85% (95% CI: 75%-93%). The prevalence of intraventricular dyssynchrony was similar among patients with QRS duration &lt; 0.12 s or &gt; 0.12 s (85% and 89%, respectively, p = 0.66). Twenty events were recorded. The incidence of combined events was similar in patients with or without intraventricular dyssynchrony (35% versus 38%, p = 0.9) and those with or without interventricular dyssynchrony (39% versus 34%, p = 0.73). CONCLUSION: Patients with Chagas cardiomyopathy have high intraventricular and moderate interventricular prevalence of dyssynchrony. The high prevalence is independent from the QRS width. The ventricular dyssynchrony does not have any prognostic value in patients with Chagas cardiomyopathy.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Chagas cardiomyopathy</kwd>
        <kwd>ventricular dysfunction</kwd>
        <kwd>prevalence</kwd>
        <kwd>prognosis</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Prevalence and Prognostic Value of Ventricular Dyssynchrony in Chagas' Cardiomyopathy</bold>
          </label>
          <p>
            <bold>Jussara de Oliveira Pinheiro Duarte<sup>I, II</sup>; Luiz Pereira de Magalh&#227;es<sup>II</sup>; Oto Oliveira Santana<sup>II</sup>; Leandro Barros da Silva<sup>I</sup>; Monique Sim&#245;es<sup>II</sup>; Darluce Oliveira de Azevedo<sup>II</sup>; Oct&#225;vio Alencar Barbosa J&#250;nior<sup>II</sup>; Alexsandro Alves Fagundes<sup>II</sup>; Francisco Jos&#233; Farias Borges dos Reis<sup>II</sup>; Luis Cl&#225;udio Lemos Correia<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Escola Bahiana de Medicina e Sa&#250;de P&#250;blica, Salvador, BA - Brasil</p>
      <p><sup> II</sup>Hospital Universit&#225;rio Professor Edgar Santos - UFBA, Salvador, BA - Brasil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND: </bold> Chagas' cardiomyopathy is one important cause of heart failure in Latin America. Ventricular dyssynchrony may be a factor of decompensation in the course of this disease, but there are no data on its prevalence and its main prognostic implications yet.</p>
      <p><bold>OBJECTIVE:</bold> Describe prevalence and prognostic value of ventricular dyssynchrony in Chagas' cardiomyopathy.</p>
      <p><bold>METHODS:</bold> 56 patients with Chagas' cardiomyopathy were consecutively selected by two positive serologies and an ejection fraction &lt; 45% in the echocardiogram. The echocardiogram evaluated the presence of intraventricular dyssynchrony using 3 criteria and interventricular dyssynchrony using 1 criterion. Patients were followed for 21 &#177; 14 months and cardiac events were defined as the combination of death and hospitalization.</p>
      <p><bold>RESULTS:</bold> The average age of the population was 56 &#177; 10 years, 50% males. Mean ejection fraction was 30 &#177; 8% and 87% presented functional class I/II (NYHA). The prevalence of interventricular dyssynchrony was 34% (95% CI: 22%-48%) and intraventricular dyssynchrony had a prevalence of 85% (95% CI: 75%-93%). The prevalence of intraventricular dyssynchrony was similar among patients with QRS duration &lt; 0.12 s or &gt; 0.12 s (85% and 89%, respectively, p= 0.66). Twenty events were recorded. The incidence of combined events was similar in patients with or without intraventricular dyssynchrony (35% <italic>versus</italic> 38%, p= 0.9) and those with or without interventricular dyssynchrony (39% <italic>versus</italic> 34%, p= 0.73).</p>
      <p><bold>CONCLUSION:</bold> Patients with Chagas' cardiomyopathy have high intraventricular and moderate interventricular prevalence of dyssynchrony. The high prevalence is independent from the QRS width. The ventricular dyssynchrony does not have any prognostic value in patients with Chagas' cardiomyopathy.</p>
      <p><bold>Keywords:</bold> Chagas' cardiomyopathy; ventricular dysfunction; prevalence; prognosis.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Currently, it is estimated that 10 to 18 million people are infected with Chagas' disease throughout Latin America<sup>1</sup>. Mortality due to Chagas' cardiomyopathy is closely linked to the degree of myocardial involvement<sup>2</sup>. Furthermore, the risk of death is not the same for all the patients and many authors have tried to identify clinical features that point out to patients at highest risk. Recently, Rassi et al<sup>3</sup> published a risk score with good prognostic accuracy, taking into account gender, low voltage on electrocardiogram, cardiomegaly on chest x-ray, non-sustained ventricular tachycardia, functional class and reduced ejection fraction on the echocardiogram. In addition to quantifying the degree of ventricular dysfunction, the echocardiogram has recently emerged as a tool to determine the presence of ventricular dyssynchrony, which is related to a worse prognosis in cardiomyopathies of other etiologies<sup>4-6</sup>. The prognostic value of ventricular dyssynchrony in patients with Chagas' cardiomyopathy is not known. Recently, a controversial study named "PROSPECT trial" described the value and the high interobserver variability of the echocardiogram during dyssynchrony analysis, and it is a topic to analyze in this study with chagasic patients<sup>7</sup>. Given the need for new markers of risk in this disease that may add prognostic value to Rassi's score and the lack of data on the prevalence of ventricular dyssynchrony in this population, we evaluated dyssynchrony by echocardiogram in 56 individuals with Chagas' cardiomyopathy, which were followed for 21 &#177; 14 months.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>
        <bold>Study population</bold>
      </p>
      <p>The study was conducted in the Cardiomyopathy Clinic of Federal University of Bahia. Chagas' cardiomyopathy was defined as two positive serologies for Chagas' disease (immunofluorescence and hemagglutination) and ejection fraction &lt; 45% on echocardiogram. New patients with these characteristics were consecutively selected during the period from June 2005 to August 2008. This study was approved by the local Ethical Committee. All patients provided a written informed consent. Patients with associated heart condition (hypertensive, valvular, ischemic cardiopathies) were excluded. Those with atrial fibrillation or frequent extrasystoles were excluded because these arrhythmias impair evaluation of dyssynchrony by echocardiogram.</p>
      <p>
        <bold>Study protocol</bold>
      </p>
      <p>A commercially available ultrasound system <italic>(Vingmed system FiVi/Seven, General Electric- Vingmed, Milwaukee, WI, USA)</italic> was used. Images were obtained by using a 3.5 MHz transducer, at a depth of 16 cm in the parasternal and apical views. Tissue Doppler parameters were measured from color images of three consecutive heart beats by offline analysis. The observer was not aware of the clinical condition of the patient. Intraventricular dyssynchrony was defined by the following criteria: 1) Standard deviation (SD) of the delay between the onset of R wave on electrocardiogram and the peak of S wave velocity measured on the 12 segments of left ventricle &gt; 33 ms <sup>8-10</sup>; 2) The maximum interval (MI) measured between any 2 segments &gt; 100 ms<sup>11</sup>; 3) Delay between septal-basal and basal-lateral segments (SLD) &gt; 60 ms<sup>12</sup>. For interventricular dyssynchrony, pulsed Doppler was used. It was determined as the difference in the time intervals of Q wave to the onset of flow in the pulmonary artery compared with the time intervals of Q to the onset of aortic flow, respectively. A value &gt; 40 ms is considered to be abnormal<sup>13</sup>. Ejection fraction was calculated by the modified Simpson's method. In addition, a 24-h Holter recording was performed in all patients. Rassi's score was calculated as previously validated<sup>3</sup>. Briefly, this score takes into account gender, low voltage on electrocardiogram, cardiomegaly on chest x-ray, non-sustained ventricular tachycardia, functional class III/IV and reduced ejection fraction on the echocardiogram.</p>
      <p>The patients were monitored regularly, every 3 months, through ambulatory appointments and phone calls. Clinical events such as total death, cardiovascular death, hospitalization for heart failure or arrhythmias were recorded.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>Relative frequency of interventricular and intraventricular dyssynchrony was described with 95% confidence interval. In order to identify predictors in the univariate analysis, clinical, electrocardiographic and echocardiographic data, including criteria of dyssynchrony, were compared between patients with and without events. Categorical variables were compared by Pearson's chi-square test and numeric variables by Student's t test or Mann-Whitney's test; those variables associated with events (p <italic><underline>&lt;</underline></italic> 0.10) entered the logistic regression analysis to assess independent predictors. Rassi's score was chosen instead of individual predictors. Based on a pilot study involving 28 individuals, where there was a 70% prevalence of dyssynchrony, 56 subjects were considered sufficient, given a precision error of &#177; 12% and 95% confidence interval. In relation to the prognostic value, based on the study of Rassi et al, to define independent prognostic factors in Chagas' disease and in the case of combined events, an absolute risk of 40% was estimated. Therefore, 56 patients were also considered sufficient, of which 39 had dyssynchrony and 17 did not. For the group with dyssynchrony this risk reaches 60%, and for the group without dyssynchrony this risk would be 20%. The study was given a power of 80% and an alpha equal to 5%. In the analysis of intraobserver and interobserver variability, the coefficient of variability (CV) was calculated between the measures in relation to the criteria of intraventricular and interventricular dyssynchrony. For this analysis, about 10% of the sample was used, a total of 6 patients, with two observers during the last six patients of the study. A p &lt; 0.05 was considered significant. The software SPSS 14.0 for Windows (SPSS inc, Chicago, II<italic>)</italic> was used.</p>
      <p>There are no financial or personal relationships among the authors and other people or organizations that could inappropriately influence (bias) his or her actions.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>
        <bold>Baseline characteristics</bold>
      </p>
      <p>A total of 56 patients with Chagas' cardiomyopathy were studied, 56 &#177; 10 years (36 to 79 years), 50% male, 82% African-Brazilians. They were effectively treated regarding their blood pressure, heart rate, renal function and electrolytes. In general, the patients were undergoing appropriate medical treatment with inhibitors of angiotensin converting enzyme, beta-blockers and aldosterone blockers, with 93% on regular use of medications and 87% functional class I/II. This good functional class can be explained by the specific clinic they attended (Cardiomyopathy Clinic), with different health professionals and the regular use of medications. A significant number used pacemakers (25%), 23% had right bundle branch block and 14% had left bundle branch block. The degree of left ventricular dysfunction was severe, as measured by a mean ejection fraction of 30 &#177; 8%. Cavities were dilated, with left ventricular diastolic diameter average of 66 &#177; 8 mm. Segmental disorders of the ventricular contractility were very common in this population (73%), and the most commonly affected segment was the posterior one (56%). These characteristic are shown in <xref ref-type="table" rid="t1-body3">Table 1</xref>.</p>
      <table-wrap id="t1-body3">
        <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt01-en.jpg"/></table-wrap>
      <p>
        <bold>Prevalence of dyssynchrony</bold>
      </p>
      <p>When any of the 3 criteria was considered, a significant 85% (95% CI: 75% - 93%) prevalence of intraventricular dyssynchrony was observed. Based on the standard deviation of 12 segments alone, there was a 75% prevalence (95% CI: 62% - 86%), the maximum interval criterion was present in 79% (95% CI: 65% - 88%), and the septal-lateral delay in a smaller proportion, 48% (95% CI: 35% - 62%). The prevalence of interventricular dyssynchrony was 34% (95% CI: 22% -48%) - <xref ref-type="table" rid="t2-body3">Table 2</xref>. Intraventricular dyssynchrony remained high independent from QRS width. It was present in 89% (95% CI: 74% - 97%) of patients with QRS &gt; 0.12 sec and in 84% (95% CI: 62% - 96%) of patients with QRS &lt; 0.12 sec (p = 0.66) - <xref ref-type="table" rid="en_aop02411t03-body3">Table 3</xref>. When the three criteria were separately analyzed, no significant difference was observed in relation to the percentage of QRS width in the two groups - standard deviation- 81% <italic>vs</italic> 70% (p = 0.31), maximum interval - 81% <italic>vs</italic> 75% (p = 0.85) and septo-lateral delay - 47% <italic>vs</italic> 50% (p = 0.78). Interventricular dyssynchrony was similar between the subgroups with QRS &lt; or &gt; 0.12 s (15% <italic>vs</italic> 44%, p = 0.30). <xref ref-type="table" rid="en_aop02411t03-body3">Table 3</xref> includes the medium value of the 4 criteria and p values. When the percentages were compared, there was no difference. But when the medium values were compared, it was significant for the standard deviation criterion (p = 0.03) and quite significant for the LV-RV difference criterion (p = 0.052).</p>
      <p content-type="asset">
        <table-wrap id="en_aop02411t03-body3">
          <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt02-en.jpg"/></table-wrap>
      </p>
      <table-wrap id="t2-body3">
        <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt03-en.jpg"/></table-wrap>
      <p>At the moment of dyssynchrony assessment, all paced patients were under ventricular stimulation, with the ventricular electrode in the apex of the right ventricle. In relation to patients with a pacemaker, the intraventricular dyssynchrony showed no difference when the percentage and medium values were compared (p = 0.09). However, in relation to the interventricular dyssynchrony there were differences when percentage (57% <italic>vs</italic> 24%, p = 0.04), and medium values (26 &#177; 22 ms <italic>vs</italic> 48 &#177; 33 ms, p = 0.007) were compared. When patients without a pacemaker (42) were analyzed, the prevalence of intraventricular dyssynchrony was 90% and of interventricular dyssynchrony was 24%, which can explain these results.</p>
      <p>Another observation is that segmental disorders of the ventricular contractility were significantly more prevalent in patients with intraventricular dyssynchrony, when compared with the group without dyssynchrony (81% <italic>versus</italic> 57%, p = 0.01).The segmental disorders of the ventricular contractility were a predictor of intraventricular dyssynchrony (multivariate analysis, p = 0.01).</p>
      <p>
        <bold>Prognostic value of dyssynchrony</bold>
      </p>
      <p>During a follow-up of 21 &#177; 14 months, 20 events were recorded (11 deaths and 9 hospitalizations). An incidence of combined events in patients with and without intraventricular dyssynchrony was similar (35% <italic>vs</italic> 38%, p = 0.9). When considering only deaths, the incidence was 19% and 25%, respectively (p = 0.68). Regarding the analysis of present or absent interventricular dyssynchrony, the incidence of events was 39% and 34%, respectively (p = 0.73). When considering only deaths, the incidence was 28% compared with 16% in patients without dyssynchrony (p=0.29).</p>
      <p>In the univariate analysis, the following variables were prevalent in individuals with events compared with those free of events: functional class III / IV (30% <italic>vs</italic> 6%, p = 0.02), cardiothoracic index &gt; 50% (70% <italic>vs</italic> 36%, p = 0.02). The medium Rassi's score was higher in patients with events (8), when compared with the remaining patients (6, p = 0.01) and the ejection fraction was lower in patients with events (27% &#177; 7% <italic>vs</italic> 32% &#177; 8%, p = 0.02). When examining the four criteria for dyssynchrony, the septal-lateral delay and the RV-LV difference showed p = 0.10 - <xref ref-type="table" rid="t4-body3">Table 4</xref>.</p>
      <table-wrap id="t4-body3">
        <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt04-en.jpg"/></table-wrap>
      <p>The multivariate analysis by logistic regression showed that Rassi's score was the only predictor of combined events (odds ratio<italic>-OR</italic> - 1.19; 95% CI: 1.02 to 1.40, p = 0.01). The variables of dyssynchrony- septal-lateral delay (intraventricular) and RV-LV difference (interventricular) were not significant- septal-lateral delay-OR 0.98 (95% CI: 0.97-1.00) and LV-RV difference - 1.01 (95% CI: 0.98-1.04) - <xref ref-type="table" rid="t5-body3">Table 5</xref>.</p>
      <table-wrap id="t5-body3">
        <graphic xlink:href="1678-4170-abc-96-04-0300-00037-gt05-en.jpg"/></table-wrap>
      <p>
        <bold>Interobserver and intraobserver variability</bold>
      </p>
      <p>There was a low intraobserver variability for the variable standard deviation and the maximum interval (9 and 10%, respectively) and a moderate interobserver variability (23 and 18%, respectively). Concerning the variable septal-lateral delay and the LV-RV difference, both intraobserver and interobserver variability were moderate to high (23 to 64%). Intraobserver variability (9 to 27%) was much lower when compared to the interobserver variability (18 to 64%) in any one of the four variables.</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>This is the first study that evaluated the prevalence of ventricular dyssynchrony and its clinical implications among individuals with Chagas' cardiomyopathy. Firstly, we observed that dyssynchrony is a highly prevalent condition; secondly, the presence of dyssynchrony may not affect prognosis of individuals with Chagas' cardiomyopathy.</p>
      <p>The prevalence of 85% of intraventricular dyssynchrony should be considered substantially high, especially when compared with other etiologies such as ischemic and dilated cardiomyopathy, with the prevalence reported to be 58% in patients with left bundle branch block, and 42% in those with right bundle branch block associated with divisional block<sup>14</sup>. Possible explanations for this higher prevalence in chagasic patients would be the segmental alterations secondary to areas of fibrosis associated with the chronic, diffuse inflammatory process, which is persistent and inherent to this disease<sup>15,16</sup>. In relation to the interventricular dyssynchrony, our findings were similar to those reported in other etiologies<sup>17</sup>. In this population, no significant difference was observed in relation to the prevalence based on the QRS width, just in some medium values of intraventricular dyssynchrony criteria. In relation to the interventricular criterion, this difference was more evident, but it did not reach statistical significance, just in patients with pacemakers. In the literature, the prevalence of interventricular and interventricular dyssynchrony is associated with the QRS width in other etiologies<sup>17</sup>.</p>
      <p>The degree of fibrosis in patients with Chagas' disease contradicts the benefit of resynchronization, as it has been well reported for ischemic cardiomyopathies with areas of transmural scars<sup>18,19</sup>. The septal-lateral criterion in this population was less prevalent, but there was no relation with the fibrosis area. This measurement is made at the anterior area, an area that is not normally affected by Chagas' disease. On the other hand, all the other criteria were highly prevalent and could be a factor in favor of this therapy, which has been well established in large clinical trials in other etiologies (CARE-HF and COMPANION)<sup>20-23</sup> and in small studies in the chagasic population. Silva et al<sup>24</sup> described a population of 29 patients, half of them chagasic, receiving resynchronization therapy, who evolved with clinical and ejection fraction improvement. These individuals can benefit from this therapy, but we cannot state that at this moment and a new clinical trial is necessary to define this question.</p>
      <p>Previous data reported an association between dyssynchrony and a worse prognosis in other cardiomyopathies. Cho et al<sup>6</sup> assessed dyssynchrony in 106 patients with heart failure and found that dyssynchrony was a strong predictor of severe clinical events. Similarly, Bader et al<sup>4</sup>, describing a group of 104 patients, showed that the presence of intraventricular dyssynchrony is a determinant factor of adverse cardiac events, regardless of ejection fraction and QRS<sup>4</sup>. As opposed, in the present study, the dyssynchrony did not prove to be a marker in patients with Chagas' cardiomyopathy. Possible explanations were the high prevalence, with almost everyone presenting dyssynchrony and probably the expected variability of the method used to evaluate dyssynchrony. When analyzing the precision of dyssynchrony measurements, we can see a lower intraobserver variability, when compared with the interobserver one. These reflect, in a certain way, the high variability of these values that have been previously reported in the literature<sup>7-25</sup>. The recently published study PROSPECT showed a low predictive value of the echocardiogram in relation to dyssynchrony. This current study showed a quite similar result in relation to variability, considering the same variable. Moreover, it can explain the negative result in relation to the prognosis. One suggestion is that the echocardiographic criteria in Chagas' cardiomyopathy could be different from the ones used in other cardiomyopathies. That can be observed when evaluating the high medium values in patients with Chagas' disease and QRS &lt; 0.12 s.</p>
      <p>It was decided to include patients with a pacemaker because they are very common in clinical practice and reflect an important percentage of patients with Chagas' disease. When patients without pacemakers were analyzed, the prevalence of intraventricular dyssynchrony remained high. The main limitation of the study could be the variability of the method used to evaluate dyssynchrony. The number of patients may be a question, but the number of clinical events was high. At the end of the study, it was observed that only 8 patients did not have dyssynchrony, which lead to a lower statistical power than previously calculated. Moreover, it reflects a selected group of chagasic patients with the advanced form of the disease, with strong prognostic markers, not reflecting the chagasic population as a whole. However, these results can have therapeutic implications as previously mentioned.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>In conclusion, chagasic cardiomyopathy patients have high intraventricular and moderate interventricular prevalence of dyssynchrony. The high prevalence is independent from the QRS width and remains high in the subgroup without pacemaker.</p>
      <p>In this selected group of patients with Chagas' cardiomyopathy, we could not observe a prognostic value of ventricular dyssynchrony. Larger studies are required to further investigate this issue.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Jussara de Oliveira Pinheiro Duarte, from <italic>Escola Bahiana de Medicina e Sa&#250;de P&#250;blica - Funda&#231;&#227;o Bahiana para o Desenvolvimento da Ci&#234;ncia</italic>.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
